Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models.

ABSTRACT: The rapid scale-up of research on coronavirus disease 2019 (COVID-19) has spawned a large number of potential vaccines and immunotherapies, accompanied by a commensurately large number of in vitro assays and in vivo models to measure their effectiveness. These assays broadly have the same end-goal - to predict the clinical efficacy of prophylactic and therapeutic interventions in humans. However, the apparent potency of different interventions can vary considerably between assays and animal models, leading to very different predictions of clinical efficacy. Complete harmonization of experimental methods may be intractable at the current pace of research. However, here we analyse a selection of existing assays for measuring antibody-mediated virus neutralization and animal models of infecti

SUBMITTER: Khoury DS 

PROVIDER: S-EPMC7605490 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature